# TScan Therapeutics, Inc.: Form 8-K, filed Aug 20, 2025

- Company: [TScan Therapeutics, Inc.](/companies/tcrx.md) (CIK 1783328)
- Form: 8-K
- Filed: 2025-08-20
- Accepted by EDGAR: Aug 20, 2025, 16:10 ET
- Period: 2025-08-14
- Accession: 0001193125-25-184083
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1783328/000119312525184083/d55649d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1783328/000119312525184083/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1783328/000119312525184083/d55649d8k.htm

Filed Aug 20, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-184083. Last ingested by Listed: Oct 26, 2026, 08:08 ET. No prices; not investment advice.